GDC-2394 |
| カタログ番号GC69156 |
GDC-2394は、経口摂取により有効で選択的なNLRP3阻害剤であり、同時にIL-1βも抑制し、IC50は0.4μM（人間IL-1β）および0.1μM（マウスIL-1β）です。GDC-2394はNLRP3誘導のcaspase-1活性を抑制しますが、NLRC4依存性の炎症小体活性化を抑制しません。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2238822-07-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for GDC-2394
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for GDC-2394
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *